4.5 Review

Myocarditis

期刊

PROGRESS IN CARDIOVASCULAR DISEASES
卷 52, 期 4, 页码 274-288

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.pcad.2009.11.006

关键词

Myocarditis; Dilated cardiomyopathy; Endomyocardial biopsy; Heart failure

资金

  1. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056267, R56HL056267, R01HL135165] Funding Source: NIH RePORTER
  2. NHLBI NIH HHS [R01 HL056267, R01 HL135165, R56 HL056267] Funding Source: Medline

向作者/读者索取更多资源

Myocarditis is an uncommon, potentially life-threatening disease that presents with a wide range of symptoms in children and adults. Viral infection is the most common cause of myocarditis in developed countries, but other etiologies include bacterial and protozoal infections, toxins, drug reactions, autoimmune diseases, giant cell myocarditis, and sarcoidosis. Acute injury leads to myocyte damage, which in turn activates the innate and humeral immune system, leading to severe inflammation. In most patients, the immune reaction is eventually down-regulated and the myocardium recovers. In select cases, however, persistent myocardial inflammation leads to ongoing myocyte damage and relentless symptomatic heart failure or even death. The diagnosis is usually made based on clinical presentation and noninvasive imaging findings. Most patients respond well to standard heart failure therapy, although in severe cases, mechanical circulatory support or heart transplantation is indicated. Prognosis in acute myocarditis is generally good except in patients with giant cell myocarditis. Persistent, chronic myocarditis usually has a progressive course but may respond to immunosuppression. (Prog Cardiovasc Dis 2010;52:274-288) (C) 2010 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据